PI3-Kinase Inhibitors Do Not Work in Tumor Agnostic Way | Targeted Therapeutics Toward HER2 Do Not Always Work

Edward L. Nelson, MD, UC Irvine Health talk about PI3-Kinase Inhibitors Do Not Work in Tumor Agnostic Way | Targeted Therapeutics Toward HER2 Do Not Always Work at MOASC 2018<br /> Author: moasc Added: 08/23/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | HER2